Skin Treatment - France | Statista Market Forecast

In France, the revenue generated in the Skin Treatment market market reached US$305.80m in 2024.
It is projected to experience an annual growth rate of 4.52% (CAGR 2024-2029).
When compared to other countries, the United States leads in terms of revenue, with a total of US$4.18bn in 2024.
Looking at the per capita basis, each individual in France contributes US$4.71 towards the revenue in 2024.
France's skin treatment market is experiencing a surge in demand for organic and natural products.

Definition: Skin Treatment Market
The Skin Treatment market comprises over-the-counter natural and synthetic medical skin treatment products like antibacterial preparations, acne treatment agents, antifungals. Preparations for skin treatment include medicines in the form of ointments, creams, gels, pills, capsules, washing lotions, peelings, pastes, solutions, fluids, suppositories and sprays for external and internal application. Not included are prescription medicines, preparations that are against the state law, are not explicit skin treatment drugs (e.g. painkillers) or primarily have cosmetic purposes. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional Information:
The Skin Treatment market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Agents for internal and external application
Preparations to treat skin diseases (e.g. acne treatment)

Prescription medicines
Homeopathic remedies
Painkillers
Cosmetic products
Adhesive patches

The Skin Treatment market in France has been experiencing steady growth in recent years, driven by changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Skin Treatment market in France have been shifting towards natural and organic products. Consumers are becoming more conscious of the ingredients used in skincare products and are opting for products that are free from harmful chemicals. This preference for natural and organic products is influenced by a growing awareness of the potential health benefits and environmental impact of skincare products.Trends in the market include the rise of personalized skincare solutions. Consumers are increasingly seeking customized skincare products that cater to their specific needs and concerns. This trend is fueled by advancements in technology, such as AI and machine learning, which enable companies to analyze individual skin types and create personalized formulations. Additionally, there is a growing demand for multi-functional skincare products that offer multiple benefits, such as anti-aging properties or sun protection.Local special circumstances in France also contribute to the development of the Skin Treatment market. France is known for its strong beauty and skincare industry, with a rich heritage of cosmetic brands. French consumers have a long-standing tradition of prioritizing skincare and are willing to invest in high-quality products. This cultural emphasis on skincare creates a favorable environment for the growth of the market.Underlying macroeconomic factors, such as a stable economy and increasing disposable income, also play a role in the development of the Skin Treatment market in France. As the economy improves and consumers have more discretionary income, they are more likely to spend on skincare products. Additionally, the aging population in France contributes to the growth of the market, as older consumers are more likely to invest in anti-aging and skin rejuvenation treatments.In conclusion, the Skin Treatment market in France is developing due to changing customer preferences towards natural and organic products, the rise of personalized skincare solutions, local special circumstances that prioritize skincare, and underlying macroeconomic factors such as a stable economy and an aging population.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The market has experienced significant growth during the past two decades, and pharma revenues worldwide totaled 1.48 trillion U.S. dollars in 2022.